Mitral bioprosthesis N = 174 Mitral mechanical prostheses N = 181
OR (95% CI)
AOR (95% CI)
Re-exploration forpostoperative bleeding (%) 4 (3.2%) 18 (10%) 0.2052 (0.1047–0.4023) 0.1847 (0.0838–0.3902)
10-year death (%) 6 (3.5%) 18 (10%) 0.3234 (0.1252–0.8352) 0.2426(0.0808–0.7350)
Re-operation (%) 1 (0.6%) 7 (3.7%) 0.1437 (0.0175–1.1802) 0.1078(0.0113–1.039)
Abortion 5 (3%) 27 (15%) 0.1687 (0.0634–0.4491) 0.0702(0.0209–0.2425)
Pregnancy free of anticoagulant complications 141 (81%) 101 (56%) 3.3843 (2.0957–5.4654) 1.4079 (0.6916–2.9513)
Pacemaker implantation (%) 13 (7.3%) 14 (7.5%) 0.9632 (0.4392–2.1124) 1.5411 (0.7686–3.0947)
Acute renal failure (%) 16 (9%) 18 (10%) 0.8624 (0.4253–1.7491) 0.3277 (0.1263–0.8133)
Temporary dialysis (%) 3 (2%) 7 (4%) 0.4361 (0.1109–1.7143) 0.1657(0.0329–0.7971)
Stroke (%) 6 (3.5%) 8 (4.4%) 0.7723 (0.2624–2.2733) 0.2935 (0.0777–1.0571)
30-day death (%) 1 (0.6%) 2 (1.1%) 0.5173 (0.0465–5.7576) 0.3078 (0.0239–4.0534)
Wound infection (%) 2 (1.4%) 3 (1.7%) 0.6899 (0.1139–4.1799) 0.3415 (0.0501–2.4870)
Pericardial tamponade (%) 11 (6.5%) 17 (9.3%) 0.6510 (0.2958–1.4328) 0.4687 (0.1914–1.1391)
Atrio-ventricular block grade III (%) 13 (7.5%) 16 (9%) 0.8327 (0.3881–1.7865) 0.4846 (0.1995–1.1577)
Atrial fibrillation (%) 37 (21%) 31 (17%) 1.3068 (0.7688–2.2212) 0.8886 (0.4882–1.6215)
Pneumonia (%) 17 (9.5%) 19 (10.5%) 0.9232 (0.4630–1.8410) 0.7663 (0.3602–1.6385)
Pneumothorax (%) 4 (2.3%) 9 (4.7%) 0.4497 (0.1359–1.4881) 0.4497 (0.0906–1.8750)
Pleural effusion (%) 6 (3.5%) 3 (1.4%) 2.1190 (0.5216–8.6093) 2.1614 (0.4940–9.2550)